
About


Just Weeks After COP16: CBD Secretariat Launches Stakeholder Consultations for the Operationalization of the DSI Mechanism. How Should Companies Engage?

EU Court Overturns EU-wide Botanical Food Ban
The Nagoya Protocol at Its 10th Anniversary: Lessons Learned and New Challenges from ‘Access and Benefit-Sharing’

Soon a new global tax on products developed from “digital information” from biological materials? 5 key takeaways for companies from recent UN negotiations
EU Adopts New Rules on Greenwashing and Social Impact Claims
Provisional Agreement on the EU’s Corporate Sustainability Due Diligence Directive (CSDDD): Key Elements of the Deal

WIPO proposes new Patent Disclosure obligations on Genetic Resources: What impact for companies?

Pathogen Access and Benefit-Sharing (P-ABS) under the draft WHO Pandemic Treaty: Why Many Vaccine, Therapeutic, and Diagnostic Companies will be in Scope
